Novel Interventions for Neurodevelopmental Disorders (R21/R33)
Submission Date: June 17, 2008
Estimated Total Program Funding: $2,500,000
This funding opportunity announcement (FOA) solicits Exploratory/Developmental Phased Innovation (R21/R33) grant applications that propose to develop novel interventions that will improve functioning in domains commonly affected by neurodevelopmental disorders. This FOA provides support for a first phase (R21) for initial technical development and proof-of-principle and a second phase (R33) for further development, application, and evaluation of clinical utility. It is intended that the results will support the development of larger efficacy studies of the proposed novel intervention. This FOA is intended to encourage a broad scope of new treatment approaches with potential for widespread, cost-effective application across a variety of neurodevelopmental disorders based on the targeted domain(s) of impairment. The treatment approaches may include psychopharmacologic, other physiological, cognitive, psychosocial, psychoeducational, and behavioral approaches or novel combinations of any of these approaches. Also of interest are particularly innovative and theoretically-based intervention approaches currently in clinical use that have not been adequately evaluated for safety and efficacy.
